Spots Global Cancer Trial Database for evoximab
Every month we try and update this database with for evoximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer | NCT06391008 | Stereotactic Ra... | Stereotactic ra... Evoximab Pemetrexed Albumin Paclita... Carboplatin | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |